Characterisation of a novel p53 mutation (p53N263Tfs*7) associated with li-fraumeni syndrome

BMC Cancer · Published 2026-07-29 · DOI 10.1186/s12885-026-16582-2

Free full text

Authors (9)

Francesca M. Wright, Mariela Vasileva-Slaveva, Angel Yordanov, Ivan Ivanov, Zornitsa Gorcheva, Andrea Mohr, Gareth S. A. Wright, Greg N. Brooke, Metodi V. Metodiev

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wright, F., Vasileva-Slaveva, M., Yordanov, A., et al. (2026). Characterisation of a novel p53 mutation (p53N263Tfs*7) associated with li-fraumeni syndrome. BMC Cancer. https://doi.org/10.1186/s12885-026-16582-2

Related articles

• Tumor budding and tumor-associated lymphocytic response as histopathological indicators of high-risk disease in head and neck cutaneous squamous cell carcinoma · BMC Cancer · 2026 · Same journal
• Integrative transcriptomic and experimental analyses identifies SDF4 as an astrocyte-expressed regulator of glioma progression through PI3K-AKT signaling · BMC Cancer · 2026 · Same journal
• Investigation of the significance and role of androgen receptor expression in basal/squamous type urothelial carcinoma cell line J82 cells · BMC Cancer · 2026 · Same journal
• Precision oncology meets Generative AI: assessing large language models in multidisciplinary GIST tumor boards · BMC Cancer · 2026 · Same journal
• Senescence-related immunosuppressive gene MFAP2 orchestrates stromal-immune crosstalk and immunotherapy resistance in gastric cancer · BMC Cancer · 2026 · Same journal
• The impact of STAS on recurrence-free and overall survival in T1-2N0 adenocarcinomas: a single-center retrospective study · BMC Cancer · 2026 · Same journal
• Despite improved overall stratification, the 9th edition stage IIIA category remains prognostically heterogeneous: insights from a T3N2a subgroup analysis · BMC Cancer · 2026 · Same journal
• Combining fruquintinib with TAS-102 as a promising strategy: antitumor activity in preclinical colorectal and gastric cancer xenograft models · BMC Cancer · 2026 · Same journal
• Trends in treatment and survival of stage IV non-squamous NSCLC from 2010 to 2022 · BMC Cancer · 2026 · Same journal
• Acid exposure induces pyroptosis in esophageal epithelial cells · BMC Cancer · 2026 · Same journal